SFB 548: Analyse und Modulation allergischer und autoimmunologischer Krankheiten
Forschungsverbund / Johannes Gutenberg-Universität Mainz
Bellinghausen, I; Knop, J; Saloga, J
Mechnisms of specific immunotherapy.Hautarzt. Bd. 57. H. 10. 2006 S. 855-859
Serfling, E; Klein-Hessling, S; Palmetshofer, A et al.
NFAT transcription factors in control of peripheral T cell toleranceEur J Immunol. Bd. 36. H. 11. 2006 S. 2837-43
Su, Z; Kuball, J; Barreiros, AP et al.
Nitric oxide promotes resistance to tumor suppression by CTLs.J Immunol. Bd. 176. H. 7. 2006 S. 3923-30
Atreya, R; Atreya, I; Neurath, MF
Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.Ann N Y Acad Sci. Bd. 8. H. 1072. 2006 S. 98-113
Sudowe, S; Ludwig-Portugall, I; Montermann, E et al.
Prophylactic and therapeutic intervention in IgE responses by biolistic DNA vaccination primarily targeting dendritic cells.J Allergy Clin Immunol. Bd. 117. 2006 S. 196-203
Buch, T; Waisman, A
Protection from autoimmunity by DNA vaccination against T-cell receptor.Methods Mol Med. Bd. 127. 2006 S. 269-80
Becker, C; Stoll, S; Bopp, T et al.
Regulatory T cells: present facts and future hopesMed Microbiol Immunol. Bd. 195. H. 3. 2006 S. 113-24
Maurer, M; Lopez Kostka, S; Siebenhaar, F et al.
Skin mast cells control T cell-dependent host defense in Leishmania major infections.FASEB J. Bd. 20. H. 14. 2006 S. 2460-7
Becker, CH; Fantini, MC; Neurath, MF
TGF-beta as a T cell regulator in colitis and colon cancer.Cytokine Growth Factor Rev. Bd. 17. H. 1-2. 2006 S. 97-106
Strub, A; Ulrich, WR; Hesslinger, C et al.
The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.Mol Pharmacol. Bd. 69. H. 1. 2006 S. 328-337